---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-018433"
form_type: "8-K"
ticker: "CYDY"
cik: "0001175680"
company_name: "CytoDyn Inc."
filed_at: "2022-12-07T23:59:59+00:00"
generated_at: "2026-06-21T08:00:26.391698+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# CytoDyn presents R&D update on December 7, 2022; no specific data disclosed

## Summary
- Company held an R&D Update and posted the presentation on its website.
- Presentation furnished as Exhibit 99.1, but no financial or clinical milestones are included in the filing text.
- Lack of detailed data prevents assessment of material developments.

## SEC filing metadata
- accession: 0001558370-22-018433
- form_type: 8-K
- ticker: CYDY
- cik: 0001175680
- company_name: CytoDyn Inc.
- filed_at: 2022-12-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1175680/000155837022018433/0001558370-22-018433-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1175680/000155837022018433/cydy-20221207x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-018433
- JSON: https://secwatch.observer/filing/0001558370-22-018433.json
- Plain text: https://secwatch.observer/filing/0001558370-22-018433.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.